REPORTS

Let’s Pullulate and Expand Your Business

Acne Vulgaris Treatment Market - Global Professional Analysis and Forecast to 2026

Jan 05, 2020  |  182 PAGES  |  REPORT CODE: CMM259836
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Acne Vulgaris Treatment market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the Acne Vulgaris Treatment market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Acne Vulgaris Treatment market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Acne Vulgaris Treatment industry and will help you to build a panoramic view of the industrial development.

Acne Vulgaris Treatment Market, By Type:

  • CB-0601

  • CJM-112

  • CLS-007

  • Dapsone

  • DFD-10

  • DLX-2323

  • Others

Acne Vulgaris Treatment Market, By Application:

  • Clinic

  • Hospital

  • Others

Some of the leading players are as follows:

  • Dermira Inc

  • Common Pharma Inc

  • Phosphagenics Ltd

  • Pfizer Inc

  • Ensol Biosciences Inc

  • GlaxoSmithKline Plc

  • Paratek Pharmaceuticals Inc

  • LEO Pharma A/S

  • Helix BioMedix Inc

  • Novabiotics Ltd

  • ELORAC Inc

  • Cutanea Life Sciences Inc

  • Hovione FarmaCiencia SA

  • Novartis AG

  • Galderma SA

  • Novan Inc

  • Foamix Pharmaceuticals Ltd

  • Lee's Pharmaceutical Holdings Ltd

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Acne Vulgaris Treatment Market: Technology Type Analysis

  • 4.1 Acne Vulgaris Treatment Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Acne Vulgaris Treatment Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 CB-0601

    • 4.3.2 CJM-112

    • 4.3.3 CLS-007

    • 4.3.4 Dapsone

    • 4.3.5 DFD-10

    • 4.3.6 DLX-2323

    • 4.3.7 Others

5 Acne Vulgaris Treatment Market: Product Analysis

  • 5.1 Acne Vulgaris Treatment Product Market Share Analysis, 2018 & 2026

  • 5.2 Acne Vulgaris Treatment Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Acne Vulgaris Treatment Market: Application Analysis

  • 6.1 Acne Vulgaris Treatment Application Market Share Analysis, 2018 & 2026

  • 6.2 Acne Vulgaris Treatment Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Clinic

    • 6.3.2 Hospital

    • 6.3.3 Others

7 Acne Vulgaris Treatment Market: Regional Analysis

  • 7.1 Acne Vulgaris Treatment Regional Market Share Analysis, 2018 & 2026

  • 7.2 Acne Vulgaris Treatment Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Dermira Inc

    • 9.1.1 Dermira Inc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Common Pharma Inc

    • 9.2.1 Common Pharma Inc Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Phosphagenics Ltd

    • 9.3.1 Phosphagenics Ltd Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pfizer Inc

    • 9.4.1 Pfizer Inc Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Ensol Biosciences Inc

    • 9.5.1 Ensol Biosciences Inc Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 GlaxoSmithKline Plc

    • 9.6.1 GlaxoSmithKline Plc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Paratek Pharmaceuticals Inc

    • 9.7.1 Paratek Pharmaceuticals Inc Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 LEO Pharma A/S

    • 9.8.1 LEO Pharma A/S Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Helix BioMedix Inc

    • 9.9.1 Helix BioMedix Inc Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Novabiotics Ltd

    • 9.10.1 Novabiotics Ltd Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 ELORAC Inc

    • 9.11.1 ELORAC Inc Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Cutanea Life Sciences Inc

    • 9.12.1 Cutanea Life Sciences Inc Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Hovione FarmaCiencia SA

    • 9.13.1 Hovione FarmaCiencia SA Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Novartis AG

    • 9.14.1 Novartis AG Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Galderma SA

    • 9.15.1 Galderma SA Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Novan Inc

    • 9.16.1 Novan Inc Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Foamix Pharmaceuticals Ltd

    • 9.17.1 Foamix Pharmaceuticals Ltd Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Lee's Pharmaceutical Holdings Ltd

    • 9.18.1 Lee's Pharmaceutical Holdings Ltd Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

 

The List of Tables and Figures (Totals 71 Figures and 144 Tables)

  • Figure CB-0601 Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure CJM-112 Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure CLS-007 Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure Dapsone Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure DFD-10 Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure DLX-2323 Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure Others Acne Vulgaris Treatment market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Acne Vulgaris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table North America Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table North America Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table North America Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Canada Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Canada Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Europe Acne Vulgaris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Europe Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Europe Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Europe Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Germany Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Germany Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table France Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table France Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Italy Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Italy Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Spain Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Spain Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Acne Vulgaris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table China Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table China Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Japan Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Japan Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table India Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table India Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Acne Vulgaris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table MEA Acne Vulgaris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table MEA Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table MEA Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table MEA Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Acne Vulgaris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Acne Vulgaris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Acne Vulgaris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Dermira Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Common Pharma Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Phosphagenics Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ensol Biosciences Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Paratek Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LEO Pharma A/S Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Helix BioMedix Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novabiotics Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ELORAC Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cutanea Life Sciences Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hovione FarmaCiencia SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Galderma SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novan Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Foamix Pharmaceuticals Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lee's Pharmaceutical Holdings Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top